CD4 and skin squamous cell carcinoma: Early studies suggested that a low peripheral blood CD4+ count predicted OTRs at increased risk of cSCC; however, the patients included were within their first 10 years post-transplantation where cSCC incidence is relatively low and has not been consistently replicated [55,140,141].